Authors:
BERLIN I
GIVRYSTEINER L
LECRUBIER Y
PUECH AJ
Citation: I. Berlin et al., MEASURES OF ANHEDONIA AND HEDONIC RESPONSES TO SUCROSE IN DEPRESSIVE AND SCHIZOPHRENIC-PATIENTS IN COMPARISON WITH HEALTHY-SUBJECTS, European psychiatry, 13(6), 1998, pp. 303-309
Citation: I. Berlin et F. Lavergne, EARLY PREDICTORS OF 2-MONTH RESPONSE WITH MIANSERIN AND SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND INFLUENCE OF DEFINITION OF OUTCOME ON PREDICTION, European psychiatry, 13(3), 1998, pp. 138-142
Citation: A. Schlesinger et I. Berlin, ON JFK - AN INTERVIEW WITH BERLIN,ISAIAH (EDITED TRANSCRIPT OF THE APRIL 12, 1965 INTERVIEW), The New York review of books, 45(16), 1998, pp. 31
Authors:
BERLIN I
WAROT D
LEGOUT V
GUILLEMANT S
SCHOLLNHAMMER G
PUECH AJ
Citation: I. Berlin et al., BLUNTED 5-HTLA-RECEPTOR AGONIST-INDUCED CORTICOTROPIN AND CORTISOL RESPONSES AFTER LONG-TERM IPSAPIRONE AND FLUOXETINE ADMINISTRATION TO HEALTHY-SUBJECTS, Clinical pharmacology and therapeutics, 63(4), 1998, pp. 428-436
Authors:
BERLIN I
WAROT D
LEGOUT V
GUILLEMANT S
SCHOLLNHAMMER G
PUECH A
Citation: I. Berlin et al., BLUNTED 5HT1A AGONIST-INDUCED ACTH AND CORTISOL RESPONSES AFTER CHRONIC IPSAPIRONE OR FLUOXETINE TREATMENT, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 46-46
Authors:
DELTURCO MR
CIATTO S
BJURSTAM N
BERLIN I
FAUPEL M
Citation: Mr. Delturco et al., PROSPECTIVE EVALUATION OF SURFACE ELECTRICAL POTENTIALS EARLY IN THE DIAGNOSTIC PROCESS, Breast, 6(5), 1997, pp. 316-316
Authors:
SICARD D
NOIRY JP
ABADIE E
APFELBAUM M
ARIE E
BECRET F
DUCIMETIERE P
MOLLARD JM
POCHET P
ROUFFY J
THOMAS D
VINCENS M
BERLIN I
BERTHEZENE F
BLANCHET F
BONNECARRERE M
BRUCKERT E
CLERC M
DAB W
DANINOS JM
DELAHAYE F
DELEBARRE P
DROUIN P
DUMONT E
FERRIERES J
FRUCHART JC
GASPARD P
GERSON M
GILSKI J
GROS M
GILLEMOT C
IMBERT JC
JACOTOT B
JOURDE M
LIBERATI A
LINCKDUBOST M
MENARD J
MICHEL JM
OLOMBEL MC
POLONOVSKI J
SALTIEL H
VALCKE JC
VITALDURAND D
Citation: D. Sicard et al., MEDICAL RECOMMENDATIONS AND REFERENCES ABOUT HYPOLIPIDEMIC DRUGS - ANDEM ALE-POUR-LE-DEVELOPPEMENT-DE-LEVALUATION-MEDICALE), Journal des maladies vasculaires, 22(4), 1997, pp. 249-264
Authors:
BERLIN I
SPREUXVAROQUAUX O
SAID S
LAUNAY JM
Citation: I. Berlin et al., EFFECTS OF PAST HISTORY OF MAJOR DEPRESSION ON SMOKING CHARACTERISTICS, MONOAMINE OXIDASE-A AND OXIDASE-B ACTIVITIES AND WITHDRAWAL SYMPTOMS IN DEPENDENT SMOKERS, Drug and alcohol dependence, 45(1-2), 1997, pp. 31-37
Authors:
BERLIN I
DECROIX D
MOLINIER P
HERRMANN MA
PERAUDEAU P
SCHECK F
Citation: I. Berlin et al., EFFECTS OF MORNING AND OR EVENING ADMINIS TRATION OF EFFERVESCENT CALCIUM CARBASALATE GIVEN AT A DOSE-EQUIVALENT TO 160 MG ASPIRIN DAILY ONGASTRODUODENAL TOLERABILITY/, Pathologie et biologie, 45(6), 1997, pp. 514-520
Authors:
BERLIN I
BISSERBE JC
EIBER R
BALSSA N
SACHON C
BOSQUET F
GRIMALDI A
Citation: I. Berlin et al., PHOBIC SYMPTOMS, PARTICULARLY THE FEAR OF BLOOD AND INJURY, ARE ASSOCIATED WITH POOR GLYCEMIC CONTROL IN TYPE-I DIABETIC ADULTS, Diabetes care, 20(2), 1997, pp. 176-178
Citation: I. Berlin, EFFICACY OF MIDODRINE FOR NEUROGENIC ORTHOSTATIC HYPOTENSION, JAMA, the journal of the American Medical Association, 278(5), 1997, pp. 388-388
Authors:
RADAT F
BERLIN I
SPREUSVAROQUAUX O
ELATKI S
FERRERI M
PUECH AJ
Citation: F. Radat et al., INITIAL MONOAMINE OXIDASE-A INHIBITION BY MOCLOBEMIDE DOES NOT PREDICT THE THERAPEUTIC RESPONSE IN PATIENTS WITH MAJOR DEPRESSION - A DOUBLE-BLIND, RANDOMIZED STUDY, Psychopharmacology, 127(4), 1996, pp. 370-376
Citation: I. Berlin et Y. Lecrubier, FOOD AND DRUG-INTERACTIONS WITH MONOAMINE-OXIDASE INHIBITORS - HOW SAFE ARE THE NEWER AGENTS, CNS DRUGS, 5(6), 1996, pp. 403-413
Authors:
WAROT D
BERLIN I
PATAT A
DURRIEU G
ZIELENIUK I
PUECH AJ
Citation: D. Warot et al., EFFECTS OF BEFLOXATONE, A REVERSIBLE SELECTIVE MONOAMINE-OXIDASE A INHIBITOR, ON PSYCHOMOTOR FUNCTION AND MEMORY IN HEALTHY-SUBJECTS, Journal of clinical pharmacology, 36(10), 1996, pp. 942-950
Citation: I. Berlin, FROM CREOLE TO AFRICAN - ATLANTIC CREOLES AND THE ORIGINS OF AFRICAN-AMERICAN SOCIETY IN MAINLAND NORTH-AMERICA, The William and Mary quarterly, 53(2), 1996, pp. 251-288
Authors:
SICARD D
NOIRY JP
ABADIE E
APFELBAUM M
ARIE E
BECRET F
DUCIMETIERE P
MOLLARD JM
POCHET P
ROUFFY J
THOMAS D
VINCENS M
BERLIN I
BERTHEZENE F
BLANCHET F
BONNECARRERE M
BRUCKERT E
CLERC M
DAB W
DANINOS JM
DELAHAYE F
DELEBARRE P
DROUIN P
DUMONT E
FERRIERES J
FRUCHART JC
GASPARD P
GERSON M
GILSKI J
GROS M
IMBERT JC
JACOTOT B
JOURDE M
LIBERATI A
LINCKDUBOST M
MENARD JM
MICHEL JM
OLOMBEL MC
POLONOVSKI J
SALTIEL H
VALCKE JC
DURAND DV
Citation: D. Sicard et al., HYPOLIPEMIC DRUGS, Therapie, 51(6), 1996, pp. 623-626